Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Common side effects include Genital yeast infections (particularly in women) Urinary tract infections Nasopharyngitis back pain Serious side effects These are less common but require immediate medical attention: Ketoacidosis (a buildup of acids in the blood that can occur even when blood sugar is not very high) Severe kidney infections (pyelonephritis) Necrotizing fasciitis of the perineum (a rare but life-threatening soft tissue infection) Severe allergic reactions
Note portion sizes, preparation methods, and any digestive responses
Like its injectable counterpart, it also carries approval to reduce the risk of major adverse cardiovascular events (MACE), including cardiovascular death, heart attack, and stroke, in adults with established heart disease and obesity or overweight
Obesity is a multi-faceted medical condition that typically manifests as a result of several factors, including genetic makeup, use of certain medications, lack of physical activity, excessive calorie consumption and sleep patterns
Reviews What Our Clients Say The Guide GLP-1 Weight Loss Medications: Revolutionary Solutions for Sustainable Results Introduction GLP-1 receptor agonists represent a breakthrough in medical weight management, transforming how we approach obesity treatment
Liraglutide, also marketed by Novo Nordisk for both type-2 diabetes and weight loss indication, has lost its patent exclusivity and several domestic drugmakers including GlenmarksLirafit , Eris LifesciencesErly Prefilled Pen are in distribution channels since last year
US$ 20.31
US$ 27.88
US$ 26.33
